| Outgoing Relation(s) |
| cyclooxygenase 2 inhibitor (CHEBI:50629) is a EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor (CHEBI:35544) |
| Incoming Relation(s) |
| (+)-conocarpan (CHEBI:69251) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| (E)-2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside (CHEBI:140850) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| (RS)-mallotophilippen E (CHEBI:66659) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| (S)-etodolac (CHEBI:60371) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| (S)-ketorolac (CHEBI:76228) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| (−)-larreatricin (CHEBI:69246) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| (2S,3S)-2,3-dihydro-3-hydroxymethyl-2-(4-hydroxyphenyl)-5-(E)-propenylbenzofuran (CHEBI:69248) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| meso-3,3'-didemethoxynectandrin B (CHEBI:69247) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| 1-(all-cis-docosa-7,10,13,16-tetraenoyl)glycerol (CHEBI:142499) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| 1-(4'-hydroxy-3'-methoxyphenyl)-7-phenyl-3-heptanone (CHEBI:66033) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| 13,14,15,16-tetranorlabdane-8α,12,18-triol (CHEBI:66217) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| 2-(2-hydroxy-4-methoxyphenyl)-5-(3-hydroxypropyl)benzofuran (CHEBI:69249) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| 2-(2,4-dihydroxyphenyl)-5-(E)-propenylbenzofuran (CHEBI:69250) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| 2-(4-hydroxyphenyl)-5-(E)-propenylbenzofuran (CHEBI:69252) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| 5-(3-hydroxypropyl)-2-(2-methoxy-4-hydroxyphenyl)benzofuran (CHEBI:69245) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| 5-methoxy-8-(2'-hydroxy-3'-buthoxy-3'-methylbutyloxy)psoralen (CHEBI:66697) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| 8α,19-dihydroxylabd-13E-ene-15-oic acid (CHEBI:65789) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| acetylsalicylic acid (CHEBI:15365) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| agnuside (CHEBI:2515) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| alminoprofen (CHEBI:31190) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| amfenac (CHEBI:75915) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| amfenac sodium hydrate (CHEBI:31202) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| balsaminolate (CHEBI:65464) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| bauhinoxepin F (CHEBI:65470) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| bauhinoxepin I (CHEBI:65471) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| cassiatannin A (CHEBI:69307) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| celecoxib (CHEBI:41423) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| centaureidin (CHEBI:69356) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| cimicoxib (CHEBI:76127) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| cinnamtannin B-1 (CHEBI:69304) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| cinnamtannin D-1 (CHEBI:69305) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| dehydrocostus lactone (CHEBI:244418) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| deracoxib (CHEBI:73032) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| dexketoprofen (CHEBI:76128) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| etodolac (CHEBI:4909) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| etoricoxib (CHEBI:6339) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| fenoprofen (CHEBI:5004) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| fenoprofen calcium (CHEBI:5005) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| fenoprofen calcium (anhydrous) (CHEBI:5010) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| firocoxib (CHEBI:76136) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| fomitopinic acid A (CHEBI:65902) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| fomitoside E (CHEBI:65903) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| fomitoside F (CHEBI:65904) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| gallic acid (CHEBI:30778) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| ginkgetin (CHEBI:5353) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| humulone (CHEBI:5769) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| ibuprofen (CHEBI:5855) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| impatienol (CHEBI:72634) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| impatienolate (CHEBI:66069) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| ipomotaoside A (CHEBI:70318) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| ketorolac (CHEBI:6129) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| ketorolac tromethamine (CHEBI:6130) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| LM-1685 (CHEBI:75392) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| lumiracoxib (CHEBI:73044) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| lupulin A (CHEBI:66597) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| mallotophilippen C (CHEBI:66657) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| mallotophilippen D (CHEBI:66658) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| matsudone A (CHEBI:66685) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| mavacoxib (CHEBI:76207) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| meloxicam (CHEBI:6741) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| nabumetone (CHEBI:7443) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| naproxen (CHEBI:7476) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| naproxen sodium (CHEBI:7477) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| nepafenac (CHEBI:75922) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| nimesulide (CHEBI:44445) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| nitroflurbiprofen (CHEBI:77428) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| NS-398 (CHEBI:73458) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| oleocanthal (CHEBI:85673) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| paracetamol (CHEBI:46195) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| parameritannin A-1 (CHEBI:69306) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| parecoxib (CHEBI:73038) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| quercetin 4'-O-α-L-rhamnopyranosyl-3-O-β-D-allopyranoside (CHEBI:66289) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| rataniaphenol I (CHEBI:69254) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| rataniaphenol II (CHEBI:69255) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| rataniaphenol III (CHEBI:69253) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| robenacoxib (CHEBI:76269) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| rofecoxib (CHEBI:8887) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| SC-58125 (CHEBI:8983) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| sodium (2-amino-3-benzoylphenyl)acetate (CHEBI:75918) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| sodium gallate (CHEBI:115197) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| sulindac sulfone (CHEBI:64212) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| tilmacoxib (CHEBI:73041) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| valdecoxib (CHEBI:63634) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| wogonin (CHEBI:10043) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
